Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEAS Supplementation in Diminished Ovarian Reserve
NCT02150330Phase 3Completed
- Sponsor
- Taipei Veterans General Hospital
- Start
- Jan 2013
- Primary completion
- Oct 2013
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of dehydroepiandrosterone in Diminished Ovarian Reserve (DOR), sponsored by Taipei Veterans General Hospital. Started Jan 2013; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT02150330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02150330.